Kümpfel T - Search Results

1

Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI.

Ertl-Wagner B, Koerte I, Kümpfel T, Blaschek A, Laubender RP, Schick M, Steffinger D, Kaufmann D, Heinen F, Reiser M, Alperin N, Hohlfeld R. Ertl-Wagner B, et al. Among authors: kumpfel t. Mult Scler. 2012 Jul;18(7):1000-7. doi: 10.1177/1352458511432742. Epub 2011 Dec 22. Mult Scler. 2012. PMID: 22194216

2

Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.

Ziemssen T, Kümpfel T, Klinkert WE, Neuhaus O, Hohlfeld R. Ziemssen T, et al. Among authors: kumpfel t. Brain. 2002 Nov;125(Pt 11):2381-91. doi: 10.1093/brain/awf252. Brain. 2002. PMID: 12390966

3

Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.

Kümpfel T, Hoffmann LA, Rübsamen H, Pöllmann W, Feneberg W, Hohlfeld R, Lohse P. Kümpfel T, et al. Arthritis Rheum. 2007 Aug;56(8):2774-83. doi: 10.1002/art.22795. Arthritis Rheum. 2007. PMID: 17665448 Free article.

4

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.

Krumbholz M, Pellkofer H, Gold R, Hoffmann LA, Hohlfeld R, Kümpfel T. Krumbholz M, et al. Among authors: kumpfel t. Arch Neurol. 2007 Sep;64(9):1331-3. doi: 10.1001/archneur.64.9.1331. Arch Neurol. 2007. PMID: 17846274

5

Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Obermeier B, Mentele R, Malotka J, Kellermann J, Kümpfel T, Wekerle H, Lottspeich F, Hohlfeld R, Dornmair K. Obermeier B, et al. Among authors: kumpfel t. Nat Med. 2008 Jun;14(6):688-93. doi: 10.1038/nm1714. Epub 2008 May 18. Nat Med. 2008. PMID: 18488038

6

Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.

Kümpfel T, Hohlfeld R. Kümpfel T, et al. Nat Rev Neurol. 2009 Oct;5(10):528-9. doi: 10.1038/nrneurol.2009.154. Nat Rev Neurol. 2009. PMID: 19794511

7

[Progress of therapy in patients with multiple sclerosis].

Kümpfel T, Havla J, Hohlfeld R. Kümpfel T, et al. MMW Fortschr Med. 2010 Mar 4;152(9):42-4. MMW Fortschr Med. 2010. PMID: 20384096 German. No abstract available.

8

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.

Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL, Hohlfeld R, Kümpfel T. Havla J, et al. Among authors: kumpfel t. J Neurol. 2011 Sep;258(9):1665-9. doi: 10.1007/s00415-011-5996-y. Epub 2011 Mar 23. J Neurol. 2011. PMID: 21431380

9

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.

Lehmann-Horn K, Schleich E, Hertzenberg D, Hapfelmeier A, Kümpfel T, von Bubnoff N, Hohlfeld R, Berthele A, Hemmer B, Weber MS. Lehmann-Horn K, et al. Among authors: kumpfel t. J Neuroinflammation. 2011 Oct 26;8:146. doi: 10.1186/1742-2094-8-146. J Neuroinflammation. 2011. PMID: 22027448 Free PMC article.

10

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Havla JB, Pellkofer HL, Meinl I, Gerdes LA, Hohlfeld R, Kümpfel T. Havla JB, et al. Among authors: kumpfel t. Arch Neurol. 2012 Feb;69(2):262-4. doi: 10.1001/archneurol.2011.1057. Arch Neurol. 2012. PMID: 22332194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters